Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717
- 1 January 1987
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 4 (3) , 349-356
- https://doi.org/10.1016/s0168-8278(87)80545-7
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717British Journal of Cancer, 1986
- Adriamycin treatment for hepatocellular carcinoma experience with 109 patientsCancer, 1985
- Mitozantrone as single agent therapy in hepatocellular carcinomaJournal of Hepatology, 1985
- CANCER OF THE LIVERBritish Medical Bulletin, 1984
- The natural history of hepatocellular carcinoma. A study of 100 untreated casesCancer, 1984
- Primary liver cancer. An eastern cooperative oncology group trialCancer, 1984
- Growth Characteristics of α-Foetoprotein-Secreting Human Hepatocellular Carcinoma in Athymic (Nude) MiceClinical Science, 1983
- A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in micePublished by Elsevier ,1981
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- Hepatic Artery Infusion Chemotherapy in HepatomaBMJ, 1968